PLOD3 and glioblastoma: The results from 270 or 218 glioblastoma samples from the GSE16011 and GSE13041 datasets revealed that PLOD3 overexpression was correlated with poor survival (p = 1.824e–6, p = 0.0031, respectively) (Figure 1C and 1D) and was eminently increased in the high-risk group (p = 8.84e−68, p = 2.65e−45, respectively) (Figure 1E and 1F).